MedTrace Logo

Effect of Rufinamide on Chronic Postthoracotomy Pain Syndrome

NCT02095899 · Status: WITHDRAWN · Phase: PHASE2 · Type: INTERVENTIONAL

Last updated 2015-07-21

No results posted yet for this study

Summary

The purpose of this study is to test if rufinamide has an effect on chronic neuropathic pain in patients with a post thoracotomy pain syndrome.

Conditions

  • Peripheral Nerve Injuries
  • Pain

Interventions

DRUG

Rufinamide

2x200mg up to max 2x800mg a day Titration over 20days

Sponsors & Collaborators

  • University of Zurich

    lead OTHER

Principal Investigators

  • Konrad Maurer, MD · University Hospital Zurich, Institut of Anaesthesiology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-03-31
Primary Completion
2015-05-31
Completion
2015-05-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02095899 on ClinicalTrials.gov